Marta Tiffany Lombardo

Dr. Marta Tiffany Lombardo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Cell Reports
Verified
Journal Article
Open access
RCRaniero Chimienti
Raniero Chimienti
TBTania Baccega
Tania Baccega
STSilvia Torchio
Silvia Torchio
FMFabio Manenti
Fabio Manenti
SPSilvia Pellegrini
Silvia Pellegrini
LPLorenzo Piemonti
Lorenzo Piemonti
Induced pluripotent stem cells (iPSCs) represent a source from which β cells can be derived for diabetes replacement therapy. However, their application may be hindered by immune-mediated responses. Although abrogation of major histocompatibility complex class I (MHC-I) can address this issue, it may trigger natural killer (NK) cells through missing-self recognition mechanisms. By profiling the relevant NK-activating ligands on iPSCs during in vitro differentiation into pancreatic β cells, we find that they express high levels of B7-H3 and CD155. Hypothesizing that such surface ligands could be involved in the amplification of NK-activating signals following missing-self, we generate MHC-I-deprived B7-H3−/−, CD155−/−, and B7-H3−/−/CD155−/− iPSCs. All engineered lines correctly differentiate into insulin-secreting β cells and are protected from cell lysis mediated by CD16dim and CD16+ NK subpopulations both in vitro and in vivo in NSG mice. Our data support targeted disruption of NK-activating ligands to enhance the transplant compatibility of MHC-I−/− iPSC pancreatic derivatives.

9 October 2024 in Cells
Verified
Journal Article
Open access
PDF file
MLMarta Tiffany Lombardo
Marta Tiffany Lombardo
Martina GabrielliMartina Gabrielli
Martina Gabrielli
FJFlorence Julien-marsollier
Florence Julien-marsollier
VFValérie Faivre
Valérie Faivre
TCTifenn Le Charpentier
Tifenn Le Charpentier
CVClaudia Verderio
Claudia Verderio
Human mesenchymal stem cells modulate the immune response and are good candidates for cell therapy in neuroinflammatory brain disorders affecting both adult and premature infants. Recent evidence indicates that through their secretome, mesenchymal stem cells direct microglia, brain-resident immune cells, toward pro-regenerative functions, but the mechanisms underlying microglial phenotypic transition are still under investigation. Using an in vitro coculture approach combined with transcriptomic analysis, we identified the extracellular matrix as the most relevant pathway altered by the human mesenchymal stem cell secretome in the response of microglia to inflammatory cytokines. We confirmed extracellular matrix remodeling in microglia exposed to the mesenchymal stem cell secretome via immunofluorescence analysis of the matrix component fibronectin and the extracellular crosslinking enzyme transglutaminase-2. Furthermore, an analysis of hallmark microglial functions revealed that changes in the extracellular matrix enhance ruffle formation by microglia and cell motility. These findings point to extracellular matrix changes, associated plasma membrane remodeling, and enhanced microglial migration as novel mechanisms by which mesenchymal stem cells contribute to the pro-regenerative microglial transition.